Multibillion-dollar contracts give drug makers liability shields, patent ownership and leeway on delivery dates and pricing — and promises that much of it will not be made public.
Tag: National Institutes of Health
Trial of High-Dose Blood Thinners in I.C.U. Coronavirus Patients Is Halted
Giving anticoagulants to hospitalized Covid-19 patients is routine. But high doses may sometimes do more harm than good, a safety board finds.
Moderna Vaccine Is Highly Protective and Prevents Severe Covid, Data Show
The positive review most likely ensures that the Food and Drug Administration will grant emergency authorization to a second coronavirus vaccine this week for millions of Americans.
How the US, UK and Canada Will Roll Out the Covid Vaccine
Within days, all three countries could be giving the Pfizer-BioNTech vaccine, but they have varying strategies and challenges. The U.S. plan, working through the states, is the least centralized.
Covid ‘Long-Haulers’ Need Medical Attention, Experts Urge
In a two-day meeting sponsored by the N.I.H., officials acknowledged an insufficient understanding of the issues and warned of a growing public health problem.
Moderna and Pfizer Begin Late-Stage Coronavirus Vaccine Trials
The studies each aim to enroll 30,000 people and determine whether the vaccines are safe and effective.
Prototype Vaccine Protects Monkeys From Coronavirus
A series of animal experiments may point the way to an effective human vaccine, scientists said.
Can Antibody Tests Help End the Coronavirus Pandemic?
The tests are not reliable enough to guide policy on lockdowns and reopenings, experts said. But they can help model the spread of the virus.
Why the Coronavirus Seems to Hit Men Harder Than Women
Women mount stronger immune responses to infection, scientists say. And in China, men smoke in much greater numbers.
Researchers Are Racing to Make a Coronavirus Vaccine. Will It Help?
New technology and better coordination have sped up development. But a coronavirus vaccine is still months — and most likely years — away.